14-day Premium Trial Subscription Sign Up For FreeGet Free

$133.03 (-1.10%)

Volume: 292k

Closed: Jan 21, 2022

Hollow Logo Score: -3.790

Amedisys Inc Stock Forecast

$133.03 (-1.10%)

Volume: 292k

Closed: Jan 21, 2022

Score Hollow Logo -3.790
Which way will AMED go? Request
Key Stats
P/E Ratio 19.92
Beta 1.3
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] The Amedisys Inc stock currently holds an RSI14 at 21 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.

Red day on Friday for Amedisys Inc stock after losing 1.1%
(Updated on Jan 21, 2022)

Sell candidate since 2022-01-21 PDF

The Amedisys Inc stock price fell by -1.10% on the last day (Friday, 21st Jan 2022) from $134.51 to $133.03. During the day the stock fluctuated 3.90% from a day low at $132.63 to a day high of $137.80. The price has fallen in 8 of the last 10 days and is down by -12.18% for this period. Volume has increased on the last day by 18 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 292 thousand shares were bought and sold for approximately $38.85 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -16.51% during the next 3 months and, with a 90% probability hold a price between $99.68 and $134.34 at the end of this 3-month period.

Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, January 19, 2022, and so far it has risen 0.0075%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Amedisys Inc stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $139.58 and $152.91. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss

Amedisys Inc finds support from accumulated volume at $133.02 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $5.17 between high and low, or 3.90%. For the last week, the stock has had a daily average volatility of 5.22%.

Amedisys Inc is oversold on RSI14 (21). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Amedisys Inc stock A Buy?

Amedisys Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.790

Sell Candidate Unchanged

Insiders are neutral as most recent trades are sells in Amedisys Inc

In the last 100 trades there were 74.61 thousand shares bought and 74.44 thousand shares sold. The last trade was done 16 days ago by Kusserow Paul B. K. who bough 5.78 thousand shares. For the period there has been more stocks bought than sold among the insiders, but most of the latest transaction have been insiders selling. There can be a variety of reasons for this, but the stock should be watched more closely.

Predicted Opening Price for Amedisys Inc of Monday, January 24, 2022

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price January 24, 2022 Current price
$134.49 $133.03 (Undervalued)

Remember To Visit Our YouTube Channel

Analyst Ratings

On Dec 21, 2021 "Barclays" gave "$236.00 - $213.00" rating for AMED. The price target was set to $152.84+1.4%.

Volatility and Risk
Daily Average Volatility: 5.22 %
Overall Risk: Very High High Medium Low Very Low
5.22 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $141.62
Price: $133.03
Support: $133.02

AMED Insider Trading Show all Trades



Last 100 transactions
Buy: 74 614 | Sell: 74 440 (Shares)
Date Action Amount Person Type
Jan 06, 2022 Buy 5 777 Kusserow Paul B. K. Restricted Stock Unit (Performance-Based Vesting)
Jan 06, 2022 Buy 17 330 Kusserow Paul B. K. Common Stock
Jan 02, 2022 Sell 4 866 Kusserow Paul B. K. Common Stock
Nov 30, 2021 Buy 1 000 Lechleiter Richard A Common Stock
Oct 18, 2021 Sell 800 Ginn Scott G Common Stock
Show all Insider Trades


Last 100 transactions
Buy: 74 614 | Sell: 74 440 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 139.66 4.98 %
137.68 3.50 %
136.46 2.58 %
Current price: 133.03
Support 132.51 -0.39 %
131.29 -1.31 %
129.31 -2.80 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 164.03 23.30 %
152.40 14.56 %
141.62 6.46 %
Current price 133.03
Support 133.02 -0.0075%
0 .
0 .

Click to get the best stock tips daily for free!

About Amedisys Inc

Amedisys Amedisys, Inc., together with its subsidiaries, provides home health, and hospice and personal care services. The company’ Home Health segment offers a range of services in the homes of individuals who may be recovering from illness, injury, or surgery through its skilled nurses, physical and speech therapists, occupational therapists, and aides for its patients to complete their important personal tasks. Its Hospice segment offers care that is ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE